跳至主要内容
临床试验/EUCTR2006-000357-22-BE
EUCTR2006-000357-22-BE进行中(未招募)不适用

ASSESSMENT OF GLOBAL AND REGIONAL LEFT VENTRICULAR FUNCTION AT REST AND DURING DOBUTAMINE STRESS WITH SONOVUE®-ENHANCED REALTIME 3D-ECHOCARDIOGRAPHY

Bracco ALTANA Pharma GmbH0 个研究点目标入组 100 人开始时间: 2006年10月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Availability of results from a pre-study cath-lab examination (cine-ventriculography and coronary angiography) performed within 7 days before planned stress-echocardiography
  • - Given indication for dobutamine stress-echocardiography
  • - Given written Informed Consent to participate in the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Age < 18 years
  • - Pregnant or lactating woman
  • - Known allergy against any of the ingredients of SonoVue®
  • - Unstable cardiac condition according to the contraindications for SonoVue® (cf. SPC)
  • - Any contraindication to dobutamine stress-echocardiography and/or cardiac MRI
  • - Insufficient acoustic window for adequate echocardiographic examination
  • - Participation in another clinical study with an investigational drug (up to 30 days before inclusion).

研究者

发起方
Bracco ALTANA Pharma GmbH

相似试验